Tazverik (tazemetostat) — Medica

Initial criteria

• Patient is age ≥ 16 years
• Patient has metastatic or locally advanced disease
• Patient is not eligible for complete resection

Reauthorization criteria

• Patient continues to meet initial criteria

Approval duration

1 year